# Spinal Restoration

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spinal-restoration

- Industry: Healthcare
- Headquarters: Austin, US
- Website: www.spinalrestoration.com
- Total disclosed funding: $19M
- Latest round: Series C (Oct 22, 2012)
- Investors on record: 4

## About

Spinal Restoration, Inc. is a medical device company focused on developing innovative solutions for spinal conditions. Their advanced technologies aim to improve patient outcomes through effective treatment methods.Founded in 2004 and headquartered in Austin, US, Spinal Restoration, Inc. specializes in spinal health solutions. The company has undergone developments in its business strategies but has not reported any specific pivots or changes. The founder’s history is not detailed in the available information. Spinal Restoration has completed a total of 6 deals and raised a total of USD 3.00 mn through its latest funding round, a Venture Debt round amounting to USD 2.00 mn, backed by Comerica Bank.Spinal Restoration's core offerings include advanced medical devices designed to address specific spinal conditions, enhancing patient care. Their products are tailored for a diverse clientele, catering to various healthcare providers and specialists. The company's solutions have been developed with a focus on usability and effectiveness to meet the needs of patients and healthcare professionals, with a market presence extending across North America, Europe, and parts of Asia.The revenue model of Spinal Restoration is primarily based on direct sales of their medical devices. They engage with healthcare providers through a structured pricing strategy that accommodates different client needs, ensuring access to their innovative products. The company's revenue stems from these transactions and partnerships within the medical industry, reinforcing their position in the market.Spinal Restoration plans to enhance its product line with new offerings targeting specific spinal health challenges, with anticipated launches in the coming years. Additionally, the company aims to expand its market reach into Europe and Asia by 2025, leveraging the recent funding of USD 2.00 mn to support these initiatives. The involvement of Austin Ventures in realizing their investment further indicates a strategic move towards scaling operations and product development.

## Funding rounds

- Series C, Oct 22, 2012, $3M — Austin Ventures, MB Venture Partners, Sante Ventures
- Series B, Oct 3, 2007, $16M — Austin Ventures, MB Venture Partners, Sante Ventures, Path4 Ventures

## Investors

- Austin Ventures (https://capitalatlas.ai/funds/austin-ventures) — Series B, Series C
- MB Venture Partners (https://capitalatlas.ai/funds/mb-venture-partners) — Series B, Series C
- Sante Ventures (https://capitalatlas.ai/funds/sante-ventures) — Series B, Series C
- Path4 Ventures (https://capitalatlas.ai/funds/path4-ventures) — Series B